Sagimet Biosciences Inc.
Clinical-stage biopharma developing FASN inhibitors for metabolic and fibrotic diseases.
SGMT | US
Overview
Corporate Details
- ISIN(s):
- US7867001049
- LEI:
- Country:
- United States of America
- Address:
- 155 BOVET RD., SUITE 303, 94402 SAN MATEO
- Website:
- https://sagimet.com/
- Sector:
- Manufacturing
Description
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company that develops novel fatty acid synthase (FASN) inhibitors. These therapeutics are designed to target dysfunctional metabolic and fibrotic pathways resulting from the overproduction of the fatty acid, palmitate. The company's lead product candidate is denifanstat, and its pipeline includes TVB-3567. Sagimet is exploring the application of its FASN inhibitors in treating diseases where dysregulation of fatty acid metabolism plays a key role, such as metabolic dysfunction-associated steatohepatitis (MASH), acne, and select forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-18 22:50 | English | ZIP • 8.5 KB | |||
| 2025-12-18 13:05 |
FORM 8-K
|
English | ZIP • 15.6 MB | ||
| 2025-12-17 13:05 |
FORM 8-K
|
English | ZIP • 141.9 KB | ||
| 2025-11-22 00:13 |
OWNERSHIP DOCUMENT
|
English | ZIP • 7.4 KB | ||
| 2025-11-20 22:21 | English | ZIP • 6.9 KB | |||
| 2025-11-14 22:16 | English | ZIP • 9.3 KB | |||
| 2025-11-13 13:36 |
FORM 8-K
|
English | ZIP • 15.5 MB | ||
| 2025-11-13 13:30 |
10-Q
|
English | ZIP • 1.2 MB | ||
| 2025-11-06 22:43 |
OWNERSHIP DOCUMENT
|
English | ZIP • 7.7 KB | ||
| 2025-10-23 22:06 |
FORM 8-K
|
English | ZIP • 12.3 MB | ||
| 2025-08-22 14:00 |
FORM 8-K
|
English | ZIP • 72.0 KB | ||
| 2025-08-14 23:03 | English | ZIP • 8.9 KB | |||
| 2025-08-14 23:02 |
FORM 8-K
|
English | ZIP • 255.1 KB | ||
| 2025-08-14 22:58 |
424B5
|
English | ZIP • 160.4 KB | ||
| 2025-08-14 17:58 | English | ZIP • 9.2 KB |
Automate Your Workflow. Get a real-time feed of all Sagimet Biosciences Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sagimet Biosciences Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sagimet Biosciences Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
